Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
pembrolizumab | 1.58 | 0.6 | 4724 | 54 | 13 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
pembrolizumab | 0.12 | 0.9 | 1022 | 95 |
pembrolizumab side effects | 0.22 | 0.2 | 2128 | 60 |
pembrolizumab package insert | 1.33 | 0.1 | 7491 | 64 |
pembrolizumab keytruda | 0.78 | 0.9 | 6554 | 32 |
pembrolizumab moa | 1.84 | 0.6 | 2553 | 20 |
pembrolizumab cost | 0.98 | 1 | 4929 | 14 |
pembrolizumab mechanism of action | 0.88 | 0.4 | 7956 | 99 |
pembrolizumab immunotherapy | 1.2 | 0.7 | 3854 | 32 |
pembrolizumab pi | 1.4 | 1 | 4948 | 87 |
pembrolizumab warnings | 1.98 | 0.9 | 2095 | 81 |
pembrolizumab fda approval | 0.73 | 0.8 | 4707 | 37 |
pembrolizumab action | 0.54 | 0.8 | 2386 | 46 |
pembrolizumab j code | 1.75 | 0.5 | 338 | 56 |
pembrolizumab nivolumab difference | 1.55 | 0.7 | 2402 | 61 |
pembrolizumab and nivolumab | 0.46 | 0.9 | 7344 | 28 |
pembrolizumab fda | 0.03 | 0.9 | 2795 | 84 |
pembrolizumab ema | 0.04 | 0.4 | 3896 | 66 |
pembrolizumab cervical cancer | 0.46 | 0.8 | 5320 | 61 |
pembrolizumab versus nivolumab for melanoma | 0.84 | 0.6 | 7513 | 81 |
pembrolizumab keytruda and nivolumab opdivo | 1.57 | 0.3 | 1373 | 82 |
pembrolizumab prescribing information | 0.73 | 0.4 | 597 | 83 |
pembrolizumab breast cancer | 1.66 | 0.6 | 4363 | 29 |
pembrolizumab 200 mg | 1.12 | 0.3 | 1355 | 95 |
pembrolizumab eviq | 0.34 | 0.3 | 8496 | 60 |
pembrolizumab tnbc | 1.82 | 0.2 | 9106 | 84 |